Clinical Trial Keywords:
Petri, M, Genovese, M, Engle, E, Hochberg, M. Definition, Incidence and Clinical Description of Flare in Systemic Lupus Erythematosus: A Prospective Cohort Study. Arthritis Rheum 34:937-944, 1991.
Petri M, Roubenoff R, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine is a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120-1124, 1996.
Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801-1808, 2000.
Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-double stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 44:2342-2349, 2001.
Petri MA, Measse PJ, Merrill JT, Lahita RG, Iannini MJ, Yocum DE, et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus: results of a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 50:2858-2868, 2004.
Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353:2550-2558, 2005.
Petri M, Kiani AN, Christopher-Stine L, Magder L. Coronary calcium in SLE is associated with traditional cardiovascular risk factors, but not with disease activity. J Rheumatol 35:1300-1306, 2008.
Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, et al. Cognitive function in systemic lupus erythematosus inception cohort. J Rheumatol 35:1776-1781, 2008.
Petri M, Kiani AN, Post W, Christopher-Stine L, Magder LS. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2010 Dec 10. [Epub ahead of print].
Petri M, Orbai A-M, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677-2686, 2012.
Magder LS, Petri M. Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus. Amer J Epidemiol 176:708-19, 2012.
Petri M, Bello KJ, Fang H, Magder LS. Vitamin D in systemic lupus erythematosus: modest association with disease activity and urine protein-to-creatinine ratio. Arthritis Rheum 65:1865-71, 2013.